Skip to main content
Erschienen in: Osteoporosis International 1/2010

01.01.2010 | Original Article

High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1

Erschienen in: Osteoporosis International | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Summary

Although it is known that neurofibromatosis 1 (NF1) patients suffer from vitamin D deficiency and display decreased bone mineral density (BMD), a systematic clinical and histomorphometrical analysis is absent. Our data demonstrate that NF1 patients display high bone turnover and accumulation of osteoid and that supplementation of vitamin D has a beneficial effect on their BMD.

Introduction

Neurofibromatosis 1 results in a wide range of clinical manifestations, including decreased BMD. Although it has been reported that NF1 patients have decreased vitamin D serum levels, the manifestation of the disease at the bone tissue level has rarely been analyzed.

Methods

Thus, we performed a clinical evaluation of 14 NF1 patients in comparison to age- and sex-matched control individuals. The analysis included dual X-ray absorptiometry osteodensitometry, laboratory parameters, histomorphometric and quantitative backscattered electron imaging (qBEI) analyses of undecalcified bone biopsies.

Results

NF1 patients display significantly lower 25-(OH)-cholecalciferol serum levels and decreased BMD compared to control individuals. Histomorphometric analysis did not only reveal a reduced trabecular bone volume in biopsies from NF1 patients, but also a significantly increased osteoid volume and increased numbers of osteoblasts and osteoclasts. Moreover, qBEI analysis revealed a significant decrease of the calcium content in biopsies from NF1 patients. To address the question whether a normalization of calcium homeostasis improves BMD in NF1 patients, we treated four patients with cholecalciferol for 1 year, which resulted in a significant increase of BMD.

Conclusion

Taken together, our data provide the first complete histomorphometric analysis from NF1 patients. Moreover, they suggest that low vitamin D levels significantly contribute to the skeletal defects associated with the disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33–40PubMed Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33–40PubMed
2.
Zurück zum Zitat Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593–604CrossRefPubMed Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593–604CrossRefPubMed
3.
Zurück zum Zitat Ferner RE, Huson SM, Thomas N et al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88CrossRefPubMed Ferner RE, Huson SM, Thomas N et al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88CrossRefPubMed
4.
Zurück zum Zitat Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17:548–554CrossRefPubMed Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17:548–554CrossRefPubMed
5.
Zurück zum Zitat Lammert M, Kappler M, Mautner VF et al (2005) Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161–1166CrossRefPubMed Lammert M, Kappler M, Mautner VF et al (2005) Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161–1166CrossRefPubMed
6.
Zurück zum Zitat Kuorilehto T, Poyhonen M, Bloigu R et al (2005) Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16:928–936CrossRefPubMed Kuorilehto T, Poyhonen M, Bloigu R et al (2005) Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16:928–936CrossRefPubMed
7.
Zurück zum Zitat Illes T, Halmai V, de Jonge T et al (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12:823–827CrossRefPubMed Illes T, Halmai V, de Jonge T et al (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12:823–827CrossRefPubMed
8.
Zurück zum Zitat Stevenson DA, Moyer-Mileur LJ, Murray M et al (2007) Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 150:83–88CrossRefPubMed Stevenson DA, Moyer-Mileur LJ, Murray M et al (2007) Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 150:83–88CrossRefPubMed
9.
Zurück zum Zitat Kuorilehto T, Ekholm E, Nissinen M et al (2006) NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem 54:363–370CrossRefPubMed Kuorilehto T, Ekholm E, Nissinen M et al (2006) NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem 54:363–370CrossRefPubMed
10.
Zurück zum Zitat Yu X, Chen S, Potter OL et al (2005) Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36:793–802CrossRefPubMed Yu X, Chen S, Potter OL et al (2005) Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36:793–802CrossRefPubMed
11.
Zurück zum Zitat Elefteriou F, Benson MD, Sowa H et al (2006) ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 4:441–451CrossRefPubMed Elefteriou F, Benson MD, Sowa H et al (2006) ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 4:441–451CrossRefPubMed
12.
Zurück zum Zitat Konishi K, Nakamura M, Yamakawa H et al (1991) Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci 301:322–328CrossRefPubMed Konishi K, Nakamura M, Yamakawa H et al (1991) Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci 301:322–328CrossRefPubMed
13.
Zurück zum Zitat Abdel-Wanis M, Kawahara N (2002) Hypophosphatemic osteomalacia in neurofibromatosis 1: hypotheses for pathogenesis and higher incidence of spinal deformity. Med Hypotheses 59:183–185CrossRefPubMed Abdel-Wanis M, Kawahara N (2002) Hypophosphatemic osteomalacia in neurofibromatosis 1: hypotheses for pathogenesis and higher incidence of spinal deformity. Med Hypotheses 59:183–185CrossRefPubMed
14.
Zurück zum Zitat Weinstein RS, Harris RL (1990) Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis. Calcif Tissue Int 46:361–366CrossRefPubMed Weinstein RS, Harris RL (1990) Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis. Calcif Tissue Int 46:361–366CrossRefPubMed
15.
Zurück zum Zitat Lammert M, Friedman JM, Roth HJ et al (2006) Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet 43:810–813CrossRefPubMed Lammert M, Friedman JM, Roth HJ et al (2006) Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet 43:810–813CrossRefPubMed
16.
Zurück zum Zitat Brunetti-Pierri N, Doty SB, Hicks J et al (2008) Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab 94(1):105–111CrossRefPubMed Brunetti-Pierri N, Doty SB, Hicks J et al (2008) Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab 94(1):105–111CrossRefPubMed
17.
Zurück zum Zitat Parfitt AM, Drezner MK, Glorieux FH et al (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610PubMedCrossRef Parfitt AM, Drezner MK, Glorieux FH et al (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610PubMedCrossRef
18.
Zurück zum Zitat Boyde A, Maconnachie E, Reid SA et al (1986) Scanning electron microscopy in bone pathology: review of methods, potential and applications. Scan Electron Microsc 4:1537–1554 Boyde A, Maconnachie E, Reid SA et al (1986) Scanning electron microscopy in bone pathology: review of methods, potential and applications. Scan Electron Microsc 4:1537–1554
19.
Zurück zum Zitat Boyde A, Travers R, Glorieux FH et al (1999) The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int 64:185–190CrossRefPubMed Boyde A, Travers R, Glorieux FH et al (1999) The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int 64:185–190CrossRefPubMed
20.
Zurück zum Zitat Jones SJ, Glorieux FH, Travers R et al (1999) The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: a survey using backscattered electron imaging. Calcif Tissue Int 64:8–17CrossRefPubMed Jones SJ, Glorieux FH, Travers R et al (1999) The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: a survey using backscattered electron imaging. Calcif Tissue Int 64:8–17CrossRefPubMed
21.
Zurück zum Zitat Roschger P, Paschalis EP, Fratzl P et al (2008) Bone mineralization density distribution in health and disease. Bone 42(3):456–466CrossRefPubMed Roschger P, Paschalis EP, Fratzl P et al (2008) Bone mineralization density distribution in health and disease. Bone 42(3):456–466CrossRefPubMed
22.
Zurück zum Zitat Roschger P, Plenk H, Klaushofer K et al (1995) A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities. Scan Electron Microsc 9:75–86 Roschger P, Plenk H, Klaushofer K et al (1995) A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities. Scan Electron Microsc 9:75–86
23.
Zurück zum Zitat Skedros JG, Bloebaum RD, Bachus KN et al (1993) Influence of mineral content and composition on gray levels in backscattered electron images of bone. J Biomed Mater Res 27:57–64CrossRefPubMed Skedros JG, Bloebaum RD, Bachus KN et al (1993) Influence of mineral content and composition on gray levels in backscattered electron images of bone. J Biomed Mater Res 27:57–64CrossRefPubMed
24.
Zurück zum Zitat Roschger P, Fratzl P, Eschberger J et al (1998) Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23:319–326CrossRefPubMed Roschger P, Fratzl P, Eschberger J et al (1998) Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23:319–326CrossRefPubMed
25.
Zurück zum Zitat Delling G (1974) Endokrine Knochenerkrankungen. Verh Dtsch Ges Pathol 58:176–192PubMed Delling G (1974) Endokrine Knochenerkrankungen. Verh Dtsch Ges Pathol 58:176–192PubMed
26.
Zurück zum Zitat Priemel M, Klatte TO, Kessler S et al (2007) Bone mineralization defects and vitamin D inadequacy. Histomorphometric analysis of iliac crest bone biopsies and circulating 25-[OH] vitamin D in 648 patients. J Bone Miner Res 22(Suppl 1):S83 Priemel M, Klatte TO, Kessler S et al (2007) Bone mineralization defects and vitamin D inadequacy. Histomorphometric analysis of iliac crest bone biopsies and circulating 25-[OH] vitamin D in 648 patients. J Bone Miner Res 22(Suppl 1):S83
27.
Zurück zum Zitat Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardivascular disease. AM J Clin Nutr 80(6 Suppl):1678S–1688SPubMed Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardivascular disease. AM J Clin Nutr 80(6 Suppl):1678S–1688SPubMed
28.
Zurück zum Zitat Holick MF, Chen TU, Lu Z et al (2007) Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 22(Suppl 2):V28–V33CrossRefPubMed Holick MF, Chen TU, Lu Z et al (2007) Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 22(Suppl 2):V28–V33CrossRefPubMed
29.
Zurück zum Zitat Yang FC, Chen S, Robling AG et al (2006) Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 116:2880–2891CrossRefPubMed Yang FC, Chen S, Robling AG et al (2006) Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 116:2880–2891CrossRefPubMed
30.
Zurück zum Zitat Kolanczyk M, Kossler N, Kühnisch J et al (2007) Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet 16(8):874–886CrossRefPubMed Kolanczyk M, Kossler N, Kühnisch J et al (2007) Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet 16(8):874–886CrossRefPubMed
31.
Zurück zum Zitat Stevenson DA, Schwarz EL, Viskochil DH et al (2008) Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis. Pediatr Res 63(6):697–701CrossRefPubMed Stevenson DA, Schwarz EL, Viskochil DH et al (2008) Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis. Pediatr Res 63(6):697–701CrossRefPubMed
32.
Zurück zum Zitat Gerdhem P, Ringsberg KA, Obrant KJ et al (2005) Association between 25-hydroxyvitamin D3 levels, physical activity, muscle strength and fractures in the prospective population-based OPRA study of elderly women. Osteoporos Int 16(11):1425–1431CrossRefPubMed Gerdhem P, Ringsberg KA, Obrant KJ et al (2005) Association between 25-hydroxyvitamin D3 levels, physical activity, muscle strength and fractures in the prospective population-based OPRA study of elderly women. Osteoporos Int 16(11):1425–1431CrossRefPubMed
33.
Zurück zum Zitat Houston DK, Cesari M, Ferrucci L et al (2007) Association between vitamin D3 status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 62(4):440–446PubMed Houston DK, Cesari M, Ferrucci L et al (2007) Association between vitamin D3 status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 62(4):440–446PubMed
34.
Zurück zum Zitat Bischoff-Ferrari HA, Dietrich T, Orav EJ et al (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive person aged > or = 60 years. Am J Clin Nutr 80(3):752–758PubMed Bischoff-Ferrari HA, Dietrich T, Orav EJ et al (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive person aged > or = 60 years. Am J Clin Nutr 80(3):752–758PubMed
Metadaten
Titel
High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1
Publikationsdatum
01.01.2010
Erschienen in
Osteoporosis International / Ausgabe 1/2010
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-0933-y

Weitere Artikel der Ausgabe 1/2010

Osteoporosis International 1/2010 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.